The classic clinical triad of Graves' disease is hyperthyroidism, diffuse goiter, and exophthalmos. Caring for those undergoing the orbital changes of Graves' ophthalmopathy is often challenging, even as our understanding of the disease progresses. New therapeutic modalities for both Graves' disease and the associated orbitopathy have hastened rehabilitation and improved outcomes, although this disease continues to elude definitive cure.